Approximately 1% of the tumor cells were S100+, CD34+, SOX10+, and MIB-1 positive, and the growth was diagnosed as a myxoid low-grade malignant peripheral nerve sheath tumor (MPNST). The gene discussed is CD34; the disease is neoplasm.